🇺🇸 FDA
Pipeline program

Sarcosine and D-serine

NSC-94-2314-B-039-026

Phase 2 small_molecule completed

Quick answer

Sarcosine and D-serine for Schizophrenias is a Phase 2 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Schizophrenias
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials